Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Shares Outstanding (Entity) (2010 - 2026)

Lite Strategy (LITS) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.54 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.73 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 252.88 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 575.47 Mn
10 Lite Strategy 35.71 Mn 28.17 Mn - 35.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 36.79 Mn
Dec 31, 2025 36.79 Mn
Sep 30, 2025 29.48 Mn
Jun 30, 2025 6.66 Mn
Mar 31, 2025 6.66 Mn
Dec 31, 2024 6.66 Mn
Sep 30, 2024 6.66 Mn
Jun 30, 2024 6.66 Mn
Mar 31, 2024 6.66 Mn
Dec 31, 2023 6.66 Mn
Sep 30, 2023 6.66 Mn
Jun 30, 2023 6.66 Mn
Mar 31, 2023 6.66 Mn
Dec 31, 2022 6.66 Mn
Sep 30, 2022 6.66 Mn
Jun 30, 2022 6.66 Mn
Mar 31, 2022 6.66 Mn
Dec 31, 2021 6.65 Mn
Sep 30, 2021 5.63 Mn
Jun 30, 2021 5.63 Mn